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Department of Physiology and Biochemistry, University of Malta, Msida, Malta
Stroke is a complex and devastating neurological condition with limited treatment
options. Brain edema is a serious complication of stroke. Early edema formation can
significantly contribute to infarct formation and thus represents a promising target.
Aquaporin (AQP) water channels contribute to water homeostasis by regulating water
transport and are implicated in several disease pathways. At least 7 AQP subtypes
have been identified in the rodent brain and the use of transgenic mice has greatly
aided our understanding of their functions. AQP4, the most abundant channel in the
brain, is up-regulated around the peri-infarct border in transient cerebral ischemia
and AQP4 knockout mice demonstrate significantly reduced cerebral edema and
improved neurological outcome. In models of vasogenic edema, brain swelling is more
pronounced in AQP4-null mice than wild-type providing strong evidence of the dual
role of AQP4 in the formation and resolution of both vasogenic and cytotoxic edema.
AQP4 is co-localized with inwardly rectifying K+-channels (Kir4.1) and glial K
+ uptake
is attenuated in AQP4 knockout mice compared to wild-type, indicating some form
of functional interaction. AQP4-null mice also exhibit a reduction in calcium signaling,
suggesting that this channel may also be involved in triggering pathological downstream
signaling events. Associations with the gap junction protein Cx43 possibly recapitulate
its role in edema dissipation within the astroglial syncytium. Other roles ascribed to AQP4
include facilitation of astrocyte migration, glial scar formation, modulation of inflammation
and signaling functions. Treatment of ischemic cerebral edema is based on the various
mechanisms in which fluid content in different brain compartments can be modified. The
identification of modulators and inhibitors of AQP4 offer new therapeutic avenues in the
hope of reducing the extent of morbidity and mortality in stroke.
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Introduction
Stroke is one of the primary causes of death in many developed countries, with a slow increase
in prevalence worldwide (Kim et al., 2010). The most common type, ischemic stroke, accounts for
approximately 85% of deaths and occurs when reduced cerebral blood flow caused by acute or grad-
ual vessel obstruction results in damage to a local area of the brain (Green et al., 2003; Hossmann,
2006). The pathophysiology of ischemic stroke integrates several complex molecular and hemody-
namic processes of the neurovascular unit and a sound understanding of the details of these events
is required if treatment design strategies are to be successful.
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Aquaporins (AQPs) are a family of specialized water chan-
nels expressed on heterogeneous cell types, of which at least three
major types are found in the central nervous system (Papadopou-
los et al., 2007). Their discovery has greatly improved our knowl-
edge on how water flux is absorbed and released across various
membranes, and has provided insight on water distribution
in the various brain compartments (Agre, 2004). They con-
tribute significantly to water homeostasis in the body and have
important roles in both physiology and in heterogenous diseases
(Papadopoulos et al., 2007).
Since normal brain function is intricately linked to water
homeostasis (Amiry-Moghaddam and Ottersen, 2003c), it is not
surprising that AQPs have taken center stage in studies related
to various brain diseases since their discovery. With pathophys-
iological features including edema and inflammation, ischemic
stroke is one of such diseases deserving attention. Given that
edema is one of the principal mediators of ischemic injury, this
review aims to highlight recent advances in knowledge of AQP
channels in the brain, and on their putative roles in the evolving
pathophysiology of ischemic stroke. The development of phar-
macological tools targeting AQPs to reduce edema and mitigate
glial scar formation will also be addressed.
Ischemic Stroke and Cerebral Edema
In the adult brain, water is distributed among various compart-
ments that include the cerebrospinal fluid (CSF), blood, and
the intracellular and interstitial components of the parenchyma.
Fluid movement across vascular, ventricular and parenchymal
compartments is controlled by osmotic gradients and hydrostatic
pressure differences and is crucial for maintaining normal physi-
ological function (Papadopoulos et al., 2007). The neurovascular
compartment consisting of vasculature, neurons and astrocytes
is critical for the control of this water movement (Badaut et al.,
2011). The recently coined “glymphatic system” by Iliff and Ned-
ergaard (reviewed in Iliff and Nedergaard, 2013), attempts to
further delineate water movement facilitated via a paravascular
route between glial and vascular cells that may include previ-
ously unrecognized pathways (Figure 1). In ischemic stroke, a
key aggravating factor is the presence of edema. Brain volume is
limited by the rigidity of the skull, so that even minute increases
in volume lead to an increase in intracranial pressure and com-
pression of neural tissue and vasculature. Edema therefore has
a crucial impact on morbidity and mortality in stroke (Klatzo,
1985). Current treatment of cerebral edema is limited to osmotic
agents such asmannitol and surgical decompression, but these do
not address the problem at a molecular level.
Edema Formation in Stroke
Pathophysiology
In ischemic stroke, edema is commonly observed within the
first week, reaching a peak 24–72 h following the ischemic event
(Marmarou, 2007) and is usually accompanied by alterations
in the neurovascular unit at the molecular and cellular levels
(Badaut et al., 2011). Ischemic brain edema can be differenti-
ated pathophysiologically into an early cytotoxic form, arising
a few minutes following ischemia and a later vasogenic type
appearing as a result of blood-brain barrier (BBB) breakdown
after around 4–6 h. More recent denominations including anoxic
and ionic edema focus on the etiology of the edema rather than
on the location of its effects (Simard et al., 2007; Badaut et al.,
2011).
Ischemic edema follows a characteristic time course and is
vascular threshold-dependent. It first manifests at perfusion val-
ues of ∼30% of control when stimulation of anoxic metabolism
causes an increase of brain tissue osmolarity and associated cell
swelling. At flow values below 20% of control anoxic depolar-
ization and failure of cellular ionic regulation further elevate
intracellular osmolarity and the associated cell swelling (Hoss-
mann, 2006). During this acute phase, tissue injury is the direct
consequence of ischemia-induced energy failure and depolariza-
tion consequent to the cessation of Na+/K+ -ATPase and Na+
co-transporter. Intracellular accumulation of ions and failure of
reuptake mechanisms results in disruption of ionic gradients
(Choi and Rothman, 1990). Osmotic water influx causes astro-
cyte and dendritic swelling (Kimelberg, 2005), and a diminu-
tion of the extracellular compartment, but does not alter the net
water content (Nicholson and Sykova, 1998). The shift of fluid
is reflected by a decrease in the apparent diffusion coefficient
of water, which is the reason for the increase in signal inten-
sity in diffusion-weighted MR imaging (Hoehn-Berlage et al.,
1995). Physiologically, astrocytes are capable of rapidly respond-
ing to changes in extracellular osmotic pressure by an initial
swelling and consequent regulatory volume decrease. This regu-
latory volume decrease is controlled by ion and water movements
and is thought to be under the control of volume-activated K+-
and Cl−-channels (O’Connor and Kimelberg, 1993). In ischemia,
these mechanisms may still function but may be overwhelmed,
which hampers the ability of astrocytes to maintain their vol-
ume and water content. Cellular edema is primarily a pathol-
ogy of astroglia, and astroglial swelling becomes apparent within
30min of onset of focal ischemia (Pantoni et al., 1996). The ini-
tiation of astrocyte swelling is probably largely associated with
increased levels of glutamate and K+ which activate astrocyte-
mediated uptake and trigger cellular osmotic overload. Sub-
sequent activation of water influx through AQPs, which are
expressed abundantly in astrocyte membranes, results in a dra-
matic increase in their volume (Nielsen et al., 1997) which may
also be augmented during hypoxia by lactacidosis (Walz and
Mukerji, 1988).
Astroglial swelling can initiate a variety of secondary effects,
which exacerbate brain damage. In particular, swelling of perivas-
cular astrocytes and astrocyte end-feet may compress brain ves-
sels and limit vascular circulation. Vascular congestion from this
mechanism contributes to the incomplete filling of brain vessels
during reperfusion following focal ischemia, known as the no-
reflow phenomenon (Ames et al., 1968). Swelling of astrocytes
can result in opening of volume-regulated ion channels which are
permeable to glutamate and other excitatory amino acids whereas
release of the latter can induce or exacerbate excitotoxic cell
death. Prominent swelling of astrocytes can also severely reduce
the extracellular space volume which contributes to a concentra-
tion of extracellular glutamate and K+. A several-fold reduction
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FIGURE 1 | The glymphatic system regulates cerebrospinal fluid
(CSF) and interstitial fluid (ISF) exchange in the brain. (A)
Illustration of the main fluid compartments in the brain.
(B) Diagram of fluid influx via penetrating arteries and efflux along
a subset of large-caliber veins. (C) Diagram of proposed molecular
mechanisms governing paravascular CSF–ISF exchange.
Abbreviations: paravascular space, PVS; solute carrier, SLC; zonula
occludens, ZO; connexin, CNX; Na+-K+-ATPase, NKA; intracellular
fluid, ICF; aquaporin-4, AQP4. Reproduced with permission from
Thrane et al. (2014).
in extracellular space is sufficient to increase the concentration of
extracellular glutamate to excitotoxic levels (Choi and Rothman,
1990).
With the development of tissue necrosis and the degradation
of the basal lamina BBB integrity is lost and after 4–6 h albumin
and other serum proteins begin to leak from the blood into the
brain following disturbance of endothelial tight junctions (Wang
and Shuaib, 2007). This event initiates a delayed vasogenic type
of edema which enhances the water content of the tissue by more
than 100%. In large brain infarcts, the volume increase of the
edematous brain tissue may be so pronounced that transtento-
rial herniation causes compression of the midbrain. Under clin-
ical conditions, this malignant form of brain infarction is by far
the most dangerous complication of stroke and an indication for
decompressive craniectomy (Walz et al., 2002). In a study of tran-
sient middle cerebral artery occlusion (MCAO) in cats, Toyota
et al. (2002) showed that glutamate elevation during ischemia is
not only a reliable predictor of secondary deterioration but also
an important cause leading to a malignant course with decreased
cerebral perfusion pressure. Toyota et al. (2002) hypothesized
that glutamate elevation may lead to infarct enlargement and
further enhancement of glutamate eﬄux through positively con-
trolled feedback mechanisms. The formation of cytotoxic and to
a lesser extent of vasogenic edema requires flow of water through
AQP channels located in the plasma membrane (Badaut et al.,
2002). Inhibition of AQP water conductance at various stages
during stroke may therefore reduce the severity of ischemic brain
edema.
Countering Edema
Under physiological conditions, edema is efficiently cleared
through translocation via the ependyma into the ventricular CSF,
the glia limitans into the subarachnoid CSF, and through the BBB
into the blood. The elements of this exit route strongly express the
AQP4 transporter and the relative contribution of each to reso-
lution of edema may depend on the surface area of each barrier
and the intracranial pressure (Tait et al., 2008).
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Vasogenic edema has traditionally been thought to be cleared
primarily by bulk flow of fluid through the extracellular space,
through the glia limitans into the ventricles and subarachnoid
space, and to a lesser extent through astrocyte foot processes
and capillary endothelium into the blood. Extravasation of albu-
min protein following BBB breakdown further increases the bulk
flow of water and edema in the extracellular compartment of
the brain. In a series of experiments conducted in AQP4-null
mice, Papadopoulos and colleagues have shown strong evidence
that AQP4-dependent transcellular water flux is central to the
movement of edema fluid across the astrocyte cell membranes
of the glia limitans into the CSF (Papadopoulos et al., 2004).
These findings support earlier results by Reulen and colleagues,
who demonstrated movement of edema fluid toward the ven-
tricle (Reulen et al., 1978). There have been several reports of
altered AQP4 expression in astrocytes in cases of brain edema
in both human and rodent brain (reviewed in Papadopoulos and
Verkman, 2013 and others). The severity of the lesion produc-
ing interstitial edema was associated with the up-regulation of
AQP4 and this could potentially be a protective mechanism for
countering edema accumulation (Tourdias et al., 2009). Thus, the
up-regulation of AQP4 expression could be an important deter-
minant of the overall water content on the basis of its involve-
ment in the elimination of edema from the brain parenchyma
(Figure 2A).
The Aquaporin Channel Family
The members of the AQP water channels consist of small
(∼30 kDa/monomer) hydrophobic, integral membrane proteins.
These are expressed widely in the animal and plant kingdoms
with 13 subtypes having been identified so far in mammals. The
FIGURE 2 | Schematic drawing depicting three distinct roles of
AQP4 (green circles) in brain function. (A) Brain water balance, (B)
astroglial cell migration and (C) neuronal excitation. (A) Green. Routes of
edema formation in the two types of brain edema (cytotoxic – through
AQP4, vasogenic – through interendothelial spaces). Orange. Edema fluid is
eliminated by AQP4 through the glial limitans into subarachnoid CSF,
through ependyma and sub-ependymal astroglia into ventricular CSF, and
through astroglial pericapillary foot processes into blood. (B) AQP4
polarizes to the leading edge of migrating astroglia and accelerates cell
migration. AQP4 facilitates water entry into lamellipodial protrusions in
response to intracellular hyperosmolality produced by actin
depolymerization and ion influx. (C) AQP4 deletion reduces neuroexcitation.
Active neurons (neuron a) release K+ into the extracellular space (ECS).
Increased extracellular [K+] depolarizes quiescent neurons (neuron b).
AQP4 deletion increases ECS volume and reduces astroglial cell K+
reuptake. This buffers the increase in extracellular [K+] by active neuron a,
preventing depolarization of quiescent neuron b. Reproduced with
permission from Papadopoulos and Verkman (2008).
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existence of a channel pore for water was hypothesized before
the identification of the protein and was based on observa-
tions that red blood cells have higher water permeability than
expected for an equivalent surface area of a lipid bilayer mem-
brane. This hypothesis was confirmed in 1992 by Peter Agre
and colleagues with the identification of AQP0, the first mem-
ber of the AQP family of water channels (Preston et al., 1992).
Besides functioning as a water channel, APQ0 also has a struc-
tural role, being required to maintain the transparency and opti-
cal accommodation of the ocular lens. The monomeric units of
AQPs consist of six transmembrane α-helices (M1, M2, M4–
M7, and M8), two half helices (M3 and M7) and five connect-
ing loops around a water pore (Figure 3). Their specificity for
water may depend on two conserved Asn-Pro-Ala (NPA) motifs
in the half helices M3 and M7, which contain inward-facing
asparagine polar side chains that prevent proton conduction
(Murata et al., 2000). Together with the α-carbonyl groups, the
NPA motifs act as hydrogen-bond donors and acceptors that
allow the transport of water or glycerol through the pore (Fu
et al., 2000; Sui et al., 2001). Molecular simulations based on
the AQP1 crystal structure suggest single-file passage of water
through the narrow <0.3 nm pore, in which steric and elec-
trostatic factors prevent transport of protons and other small
molecules (Sui et al., 2001). AQPs have no gating system for water
permeability through their channel pore and therefore functions
of APQs depend on their level of expression in the plasma mem-
brane. The transport function of many AQPs can be inhibited
by non-specific, mercurial sulfhydryl-reactive compounds, such
as mercury chloride and there is growing interest in the design
of non-toxic, AQP-selective inhibitors (Verkman, 2001; Castle,
2005).
These water-conducting, protein-based channels are divided
into 2 major groups, on the basis of their permeability. AQP0,
AQP1, AQP2, AQP4, AQP5, AQP6, and AQP8 comprise the
pure water channel family and appear to be exclusive water
channels. AQP6 and AQP8 are strictly in this group on the basis
of sequence analysis, although AQP6 is permeated by anions
(Yasui et al., 1999) and AQP8 might be permeated by urea and
water (Ishibashi et al., 1997; Ma et al., 1997). Members of the sec-
ond group include AQP3, AQP7, AQP9, and AQP10 known as
aquaglyceroporins and are permeable to water, as well as glycerol
and urea. AQP9 is permeable to water, glycerol, urea, purines,
pyrimidines, and monocarboxylates (Badaut et al., 2002, 2011).
Aquaporin Distribution in the Central
Nervous System
AQPs in the CNS facilitate water transport between the major
brain compartments: the CSF space (including cerebral ventri-
cles and subarachnoid space), the brain parenchyma (intracellu-
lar and extracellular space) and the intraventricular compartment
(Zador et al., 2009; Papadopoulos and Verkman, 2013). In mouse
brains, the AQPs that predominate in these compartments are
mostly AQP1 and AQP4 (Nielsen et al., 1997). Only a subset
of the 14 known AQPs, namely AQP1, AQP4 and AQP9, are
expressed in the CNS. Each type of AQP has a unique expres-
sion pattern among tissues and during development factors such
as injury may alter this expression. Sites of AQP expression
may also give an indication to what function pertains to each
type (Papadopoulos et al., 2007). Genetic defects involving aqua-
porin genes have been implicated in several human diseases.
Most significantly, mutations in the AQP2 gene cause hereditary
nephrogenic diabetes insipidus (Deen et al., 1994) and cataract
formation with mutation in AQP0 (Verkman and Mitra, 2001).
Aquaporin 4—the Major Aquaporin in the
Brain
The glial membrane channel AQP4, previously named
as the mercury-insensitive water channel by Verkman’s
group is the most abundant water channel in the brain
FIGURE 3 | Aquaporin structure. (A) Generalized schematic of AQP
family proteins expanded to show connectivity. (B) Generalized
schematic of AQP family protein structure collapsed to show protein
folding, wide arrow indicates the approximate substrate path.
(C) Generalized schematic of AQP biological unit, wide arrows indicate
substrate path; the narrow arrow indicates the proposed path of
dissolved gasses through the central pore. Reproduced with permission
from Huber et al. (2012).
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(Papadopoulos and Verkman, 2007). It is predominantly
localized in astrocyte perivascular end-feet and glial limiting
membranes, at the border between the brain parenchyma and
subarachnoid CSF and beneath the ependyma bordering the
brain parenchyma and ventricular CSF (Papadopoulos and
Verkman, 2007; Zador et al., 2009). The tight organization of
astrocytes around the vasculature provides anatomical evidence
that they establish exclusive territories to form very specific
microdomains in brain gray matter. Such an association allows
receptors and channels essential for the function of astrocytes to
be densely concentrated at their vasculature. Vascular end-feet
intimately plastered along the walls of larger vessels typically
co-express AQP4 and glial fibrillary acidic protein (GFAP). By
contrast, astrocyte end-feet in contact with capillaries are AQP
positive but only occasionally GFAP-positive (Figure 4). AQP4 is
not expressed in other CNS cell types such as neurons, meningeal
cells or oligodendrocytes (Papadopoulos et al., 2007), but has
been reported in microglia following lipopolysaccharide (LPS)
injection (Tomás-Camardiel et al., 2004).
Freeze-fracture and electron microscopy have shown the
glia limitans to contain orthogonal arrays of particles (OAPs)
or microcrystalline assemblies of AQP4 (Agre et al., 2002;
Amiry-Moghaddam et al., 2010). The latter was confirmed
through studies using transgenic mice which revealed that brains
of AQP4-null mice were devoid of OAPs and from immunogold
labeling of OAPs in the brain (Manley et al., 2000). These OAPs
may play a central role in cerebral water balance and the associa-
tion of AQP4 to OAPs has been suggested as augmenting its effi-
ciency as a water transporter by increasing its water permeability
and aiding its interaction with other proteins such as ion channels
(Manley et al., 2000; Silberstein et al., 2004). AQP4 exists in two
isoforms of which M1 occurs as individual tetramers and M23
forms OAP assemblies (Furman et al., 2003). The ratio between
the expression of the long and the short AQP4 splice variant
(AQP4m1 and AQP4m23) determines the size of the OAPs (Rash
et al., 2004). The AQP4m23 isoform stabilizes the structure of
the OAPs and an increase of its expression induces an increase in
the size of the OAPs (Rash et al., 2004). Co-immunoprecipitation
has demonstrated association of AQP4 with the dystrophin pro-
tein complex which is essential for anchoring of AQP4 to astro-
cyte end-foot processes (Neely et al., 2001). α-syntrophin, a
PDZ-domain containing protein of the dystrophin associated
protein complex is partly responsible for AQP4 anchoring to
end-feet membranes and contributes to its polarized expression
(Puwarawuttipanit et al., 2006). Targeted disruption of the gene
encoding α-syntrophin results in inconsistencies including loss
of perivascular AQP4 (Vajda et al., 2002).
AQP4 has been ascribed several roles within the CNS. These
include control of water flux, neural signal transduction and pro-
motion of astrocyte migration (Tait et al., 2008). Its polarized
location in proximity to the vasculature also suggests a role in
gaseous exchange including that of O2, CO2, and NO (Kimel-
berg and Nedergaard, 2010). Since it is expressed in cell types
which perform an osmoregulatory role, AQP4 is thought to be
a central modulator of serum osmolarity and although some of
its roles remain controversial, strongest evidence points to AQP4
function in edema (Manley et al., 2000; Verkman, 2005).
Studies using AQP4- knockout mice (AQP-KO) and wild-type
have aided in the elucidation of various roles of AQP4 in ischemia
(Papadopoulos and Verkman, 2007). Considering the increased
ratio of astrocytes to neurons from rodent to human brain, AQPs
may play a more significant role in human than in rodent CNS
(Papadopoulos and Verkman, 2013).
AQP4 and Edema Formation
Astrocytes, being the dynamic, self-organizing, auto-regenerative
housekeeping brain cells regulate several brain processes and the
presence of heterogeneous transporters, receptors and ion chan-
nels are testament to their significance in cerebral homeostasis.
Polarized AQP4 channel expression with high levels on perivas-
cular astrocyte end-feet (Amiry-Moghaddam et al., 2003a), sug-
gests a homeostatic role in water exchange between brain and
vasculature. The role of AQP4 in ischemia was first described in
FIGURE 4 | Distribution of AQP4 and coverage of cortical astrocyte
microdomains at the gliovascular interface. (A) Double immunolabeling
of AQP4 (red) and GFAP (green). AQP4 immunolabeling reveals that the
entire network of vessels, including capillaries, is covered by astrocyte
processes, albeit GFAP negative. Smaller vessels and capillaries are mostly
GFAP negative but display intense labeling against the astrocyte-specific
channel AQP4. The AQP4 labeling reveals continuous coverage by astrocyte
end feet. Scale bar: 60µm. Reproduced with permission from Society of
Neuroscience by Simard et al. (2003). (B) Two-photon imaging of enhanced
green-fluorescent protein (eGFP)-expressing astrocytes on the cortical
surface in live mouse brain, illustrating the territorial astrocyte domains and
the dense array of processes associated with the vasculature. The
vasculature was labeled with Texas Red-dextran dye that labels the plasma
and outlines the pial vasculature. Scale bar: 20µm.
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an AQP4-KO model of combined cytotoxic and vasogenic brain
edema (ischemic stroke model) and a cytotoxic brain edema
model (acute water intoxication model) (Manley et al., 2000). In
the ischemic stroke model, the presence of AQP4 was shown to
aggravate post-ischemic cytotoxic edema as measured by post-
ischemic hemispheric enlargement, while AQP4-KOmice exhib-
ited an opposing effect and an improved neurological outcome
(Manley et al., 2000; Papadopoulos et al., 2007). In the acute water
intoxication model, AQP4-null mice hadmarkedly reduced mor-
tality from hyponatremia compared to wild-type mice. The pro-
tection afforded by the absence of AQP4may be linked to reduced
BBB water permeability and a reduced rate of water flux into
the brain parenchyma (Papadopoulos and Verkman, 2007). In α-
syntrophin-KO mice, deletion of AQP4 reduced hypo-osmolar
edema following experimental stroke more than in wild-type
mice (Amiry-Moghaddam et al., 2003a). Taken together, these
results indicate that AQP4 mediates osmotically-driven water
transport that follows ischemia (Manley et al., 2000; Badaut et al.,
2011). In cytotoxic edema, this channel limits the rate of brain
water accumulation by attenuating water flux from the vascula-
ture into the brain parenchyma in the presence of an intact BBB
(Manley et al., 2000; Papadopoulos and Verkman, 2013).
It is of interest that in vasogenic edema, AQP4 plays an oppos-
ing role. In established models of BBB disruption such as cortical
freeze injury, brain tumor, brain abscess (Bloch et al., 2005), sub-
arachnoid hemorrhage (Tait et al., 2010) and status epilepticus
(Lee et al., 2012), AQP4-null mice develop more edema than do
wild-type mice. This increased vasogenic component from dele-
tion of AQP4 reaffirms that vasogenic elimination of water into
the CSF and blood occurs via AQP4-dependent routes (Saadoun
and Papadopoulos, 2010; Papadopoulos and Verkman, 2013).
AQP4 mediates bidirectional water flux, facilitating water
influx in the evolution of cytotoxic edema and water eﬄux dur-
ing edema elimination (Papadopoulos et al., 2007). Its increased
expression at astrocyte end feet allows for polarization of func-
tion such that influx in one domain is associated with eﬄux in
another (Nagelhus et al., 2004). This bimodal role is fundamental
in formulation of therapeutic agents that target AQP4 in edema.
For instance, AQP4 inhibition could provide new treatments
by reducing cytotoxic edema during early ischemia, whereas
vasogenic edema that appears in late ischemic stroke or hemor-
rhagic stroke could be potentially controlled by increased expres-
sion of AQP4, AQP4 up-regulators or activators (Papadopoulos
and Verkman, 2007). Heterogeneous AQP4 expression patterns
and their alterations in pathological states however add to the
complexity of tackling the pathophysiology in ischemic stroke.
Recent analyses revealed that integrins are lost and the astro-
cyte end-feet detach from the basal lamina soon after onset of
ischemia (Tagaya et al., 2001; Kwon et al., 2009). This may affect
astrocyte polarization and contribute to the pathophysiological
events.
AQP4 Expression in Ischemic Stroke
AQP4 expression has been demonstrated to coincide with areas
of glial-specific swelling (Manley et al., 2000), and their dis-
tribution is spatially and temporally regulated depending on
the stroke model being employed (Badaut et al., 2011). In a
mouse model of transient cerebral ischemia, AQP4 expression
was rapidly up-regulated in perivascular end-feet, reaching a peak
1 h post-occlusion and coinciding with early cerebral swelling in
the core and border of the lesion. Another peak of expression was
observed in the penumbra after 48 h and was also correlated with
the degree of brain swelling (de Castro Ribeiro et al., 2006). This
finding may suggest that AQP4 could be the major water channel
involved in water movements after transient cerebral ischemia.
However, in models of more severe stroke, such as permanent
distal MCAO, the early expression of AQP4 was not observed,
suggesting that the brain is incapable of furnishing sufficient
AQP4 proteins in more dire situations (Badaut et al., 2011).
Differences in expression profile were also found in hypoxia-
ischemia in young rats (Meng et al., 2005) and after MCAO of
90min duration (Amiry-Moghaddam et al., 2003a). These land-
mark experiments showed that spatiotemporal up-regulation of
AQP4 is multi-factorial and dependent on differences between
stroke model and type, species and age, and severity of the
insult.
Expression patterns of AQP4 vary significantly in different
brain regions as a result of injury (Badaut et al., 2002). In a
model of MCAO and reperfusion, perivascular AQP4 expression
decreased significantly in the core area of the striatum after 24 h
of ischemia-reperfusion. In contrast, AQP4 expression in the core
of the cortex decreased after 24 h and recovered gradually after
72 h of reperfusion. This indicates that AQP4 may regulate fluid
distribution between brain parenchyma and blood in the forma-
tion and dissipation of cerebral edema after ischemia-reperfusion
(Li et al., 2008).
Early induction or down-regulation of AQP4 are also seen in
various pre-conditioning experiments, in which application of
sub-toxic or noxious stimuli aid in identification of potentially
protective and regenerative endogenous mechanisms (Dirnagl
et al., 2009; Hirt et al., 2009a; Hoshi et al., 2011). The involvement
of astrocytes in synaptic function and plasticity via integration,
processing and storage of information enables proper control
of the brain homeostatic milieu. Since astrocytes are principal
components of the brain’s adaptive processes, the relationship
of astrocyte AQP4 expression patterns to pre-conditioning stim-
uli seems to offer important mechanistic insights (Hoshi et al.,
2011). In a thrombin pre-conditioning (TPC) model, Hirt and
colleagues showed that exposure to the serine protease prior to
ischemia was neuroprotective. Through immuno-histochemical
and Western blot analysis, AQP4 expression was more pro-
nounced in TPC mice than in saline-treated mice and this was
correlated with reduced edema at 1 h post-stroke (Hirt et al.,
2009b). Evidence of down-regulation of AQP4 was also seen
with the use of 3-nitropropionic acid (3NP).This mitochondrial
toxin at sub-toxic levels may induce ischemic tolerance through
the inhibition of succinate dehydrogenase in the tricarboxylic
acid cycle and may lead to the generation of reactive oxygen
species (ROS). Administration of 3NP to rats prior to ischemia
resulted in down-regulation of AQP4 and suppression of post-
ischemic edema. The mechanism for this down-regulation may
involve ROS-induced alteration of signal transduction through
the glutathione antioxidant defense of astrocytes or by direct
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modification of the reversible oxidation of AQP4 (Hoshi et al.,
2011). However, these findings need to be corroborated by fur-
ther studies.
AQP4 expression in cultured astrocytes is enhanced by lactic
acidosis induced by ischemia which activates the anaerobic gly-
colytic pathway for synthesis of ATP. Lactic acid causes swelling
by accumulation of Na+, Cl− and water accumulation via
the coupled operation of Na+/H+ and Cl−/HCO−3 antiporters,
and the H+ monocarboxylate symporter. This increased AQP4
expression occurs at the membrane surface, without changes in
mRNA level, suggesting redistribution or post-translationalmod-
ification as key players of AQP over-expression (Morishima et al.,
2008). Putative mechanisms of AQP4 modulation of cortical
spreading depression (CSD) in stroke remain unclear.
AQP4 and KIR4.1
In ischemic stroke, energy failure leads to ionic imbalance from
modification of ionic gradient between intracellular and extracel-
lular compartments. Primary active transport or secondary active
transport leads to a net intracellular accumulation of Na+ fol-
lowed by Cl− and entry of osmotically-driven water, all of which
contribute to the initial cytotoxic swelling in stroke (Simard et al.,
2007). Increased extracellular K+ leads to the depolarization of
neurons and glia, which in turn lead to increased eﬄux of gluta-
mate. At this stage, glutamate-induced water influx and K+ clear-
ance become additional causative factors of astrocyte end-foot
swelling (Pa Santes-Morales and Cruz-Rangel, 2010).
Kir4.1 and Kir5.1 are inwardly rectifying K
+ channels exhibit-
ing distinct features (Pessia et al., 2001; Casamassima et al., 2003;
D’Adamo et al., 2011). The location of glial AQP4 and their
proximity to Kir4.1 has led to suggestions that AQP4 might aid
in transport of K+ and hence regulate rapid changes in [K+]
that occur during neural signaling (Zhang and Verkman, 2008).
Recent studies have shown that Kir4.1 channels are also part
of the orthogonal arrays owing to their expression in astro-
cytes (Kimelberg and Nedergaard, 2010) and further support
the concept of K+ spatial buffering or siphoning as first docu-
mented in retinal muller cells (Newman et al., 1984). Disruption
of the α-syntrophin gene leads to perturbed K+ homeostasis, fur-
ther indicating the close association between Kir4.1 and AQP4,
and the involvement of astrocyte end-feet in K+ homeostasis
(Amiry-Moghaddam et al., 2003b).
During neuronal excitation, K+ is released into the ECS and
efficient K+ clearance is required to prevent interference with
neuronal signaling. The astrocyte AQP4 allow efficient uptake
of water after intracellular K+ uptake and cause ECS shrink-
age, produce hyperexcitability and enhance epileptiform activ-
ity (Papadopoulos and Verkman, 2013). This shrinkage may
also occur if depolarization by K+ results in increased intracel-
lular osmolarity through the Na+/HCO−3 cotransporter, which
is strongly expressed on astrocytes (Nagelhus et al., 2004). In
the absence of AQP4, alterations in [K+]oare buffered by small
changes in ECS volume, since less water would be taken up into
astrocytes. This expansion coupled to the reduced K+ siphoning
alters neuronal excitability and lowers susceptibility to seizure
(Tait et al., 2008). Deletion of AQP4 is also associated with
impaired K+ reuptake as evidenced by altered seizure thresh-
old and duration in AQP4-null mice compared to wild-type
(Binder et al., 2006). Despite this association, confounding theo-
ries regarding the APQ4-Kir4.1 relationship abound (Figure 2C).
Direct in-vivo evidence of a decreased cellular re-uptake of
K+ from the ECS in AQP4-null mice compared to wild-type
has been reported (Verkman et al., 2006). However, later work
presented significant evidence against functional interaction of
glial AQP4 and Kir4.1 (Zhang and Verkman, 2008). In the latter
study, there was no significant difference in membrane potential,
Kir4.1K
+ current or current-voltage curves of glial cells of AQP4
null or wild-type mice, nor any difference in Kir4.1 expression
or distribution. Taken together, these results suggest that other
glial cells or ion transporters, whose expression is modified by
the absence of AQP4, are recruited to modulate local, K+ flux in
neural signaling and excitation (Zhang and Verkman, 2008).
Another hypothesis implicates an association with Kir4.1,
bicarbonate transporters and AQP4 flux. It has been suggested
that during neuronal activity, active synapses lead to shrinkage
of extracellular space accompanied by an increase in bicarbonate
transport due to K+ accumulation (Nagelhus et al., 2004). This,
coupled to secondary AQP4 water uptake may aid in the removal
of CO2 and K
+, thereby maintaining a balance between neuronal
activity and metabolite clearance. Despite conflicting theories,
APQ4 is still believed to play a key role in facilitating water uptake
and redistribution of water from sites of neuronal activity tomore
distant sites, thus mediating activity-dependent volume changes
and sustaining effective K+ clearance, whether directly or indi-
rectly (Pellerin and Magistretti, 1994; Amiry-Moghaddam et al.,
2003b; Nagelhus et al., 2004).
AQP4 and Altered Calcium Signaling in
Ischemic Stroke
The original demonstration that astrocytes display a form of
excitability based on changes in intracellular Ca2+ concentra-
tion (Cornell-Bell et al., 1990), prompted a re-examination of the
actual role of astrocytes in brain function. Astrocytes show intra-
cellular Ca2+ oscillations that occur spontaneously or in response
to different neurotransmitters and that may serve as an intracel-
lular and/or intercellular signal with relevant functional conse-
quences in the nervous system (Pasti et al., 1997). Thus, Ca2+-
mediated signaling is a critical mechanism by which astrocytes
communicate and modulate the activity of adjacent cells (Pasti
et al., 1997). Astrocyte Ca2+signaling is displayed in two modal-
ities. Firstly, long-range propagating Ca2+ waves are evoked by
electrical or mechanical stimulation, and by application of neu-
rotransmitters such as glutamate or ATP. Secondly, Ca2+ oscilla-
tions describe an increase in cytosolic Ca2+ limited to a single
cell. Exposure to various neurotransmitters including GABA,
glutamate and ATP, removal of extracellular Ca2+ or exposure
of cultured astrocytes to hypo-osmotic states are all conditions
which give rise to these Ca2+ oscillations (Berridge et al., 1998).
The latter has been applied to acute cortical slices to
allow for the observation of astrocyte-Ca2+ signaling events.
Hypo-osmotic stress induces edema with early accumulation of
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astrocyte water (Nagelhus et al., 1993; Risher et al., 2009). This
could offer a model for analysis of signaling cascades elicited by
astrocytes in vivo and has been applied to assess the effect of
AQP4 on astrocyte swelling and Ca2+ signaling (Thrane et al.,
2011). In AQP4+/+ and AQP4−/− mice exposed to mild hypo-
osmotic stress (20% reduction in osmolarity), astrocyte swelling
was observed in wild-type but was greatly reduced in AQP4−/−
mice. Ca2+ signals were only evoked in wild-type mice. More
severe hypo-osmotic stress (30% reduction in osmolarity) pro-
duced astrocyte swelling and Ca2+ spikes in both wild-type and
AQP4−/− mice, suggesting an association between Ca2+ signal-
ing, water influx via AQP4 and cellular swelling (Thrane et al.,
2011). This result implies that Ca2+ signals may be evoked by
AQP4-induced astrocyte swelling, rather than by AQP4 directly.
Edema induces astrocyte swelling and this is augmented by the
presence of AQP4. Swelling prompts release of toxic neuro-
active substances such as glutamate and ATP which mediate
aberrant Ca2+ signaling (Thrane et al., 2011). Thus, besides
operating as an osmotic flux route, this AQP type may also
trigger downstream signaling events and may exacerbate the
pathological outcome. Modulation of AQP4 may aid in atten-
uating cell swelling and secondary effects such as deleterious
ATP release. Activation of purinergic P2X7 receptors by ATP
in repair and injury may also play an indirect role in modifi-
cation of cerebral edema levels. In primary cultured astrocytes,
P2X7 receptor activation significantly attenuated AQP4 protein
expression. In addition, pre-treatment with P2X7 receptor antag-
onist in rats significantly inhibited AQP4 down-regulation in
anoxic brain injury (Lee et al., 2008). This has led to the sug-
gestion that purinergic receptor activation may confer a protec-
tive effect by attenuating cytotoxic edema through reduced water
flux.
AQP4 in Regulatory Volume Decrease
Since AQP4 is predominantly expressed on astrocytes and water
transport is inextricably coupled to major homeostatic processes
served by these glial cells, control of the extracellular milieu by
astrocytes may also involve this water channel type (Badaut et al.,
2002; Nagelhus et al., 2004; Kong et al., 2008). In ischemic stroke,
cytotoxic edema leads to neuronal and glial death with release
of their contents into the extracellular space (Papadopoulos and
Verkman, 2007). Swollen cells including astrocytes, undergo
effective cell volume regulation by the phenomenon of regu-
latory volume decrease (Badaut et al., 2002; Kimelberg, 2005;
Papadopoulos and Verkman, 2007). Extrusion of intracellular
ions, such as K+ and Cl− and amino acids including taurine and
glutamate into the ECS with decrease of the cell size to baseline in
the process has been described (Badaut et al., 2002; Papadopou-
los and Verkman, 2007). These osmotically-active solutes are
released with water so that AQP4 could be involved in the con-
trol of regulatory volume decrease (Badaut et al., 2002; Kimel-
berg, 2005). Down-regulation of AQP4 in rat cortical astro-
cytes attenuates the volume-sensitive Cl− current evoked by
hypo-osmolarity, indicating that these currents or the volume-
regulated anion channels (VRAC) that mediate them play crucial
roles together with water channels in regulatory processes that
decrease volume (Pa Santes-Morales and Cruz-Rangel, 2010).
Such volume decrease is critical in counteracting the detrimen-
tal swelling caused by pathophysiological insults in ischemic
stroke. Information regarding functional interaction of these pro-
teins, however, is still lacking while recent studies have reported
that glutamate and other co-transporters expressed on astrocytes
may facilitate water transport across areas where APQ4 is not
expressed (MacAulay et al., 2004; Kimelberg, 2005).
AQP4 and Cx43
Cx43, a primary gap junction protein (connexin) abundantly
expressed in astrocyte end-feet, mediates cell-cell interaction by
facilitating ionic and molecular transport (Rash et al., 2004) and
has recently been implicated in brain damage-related abnormal
neuro-differentiation (Samarasinghe et al., 2014). This allows for
efficient activation of many neighboring astrocytes in a relatively
short time and, with purinergic channels, has been implicated in
the generation and propagation of astrocyte Ca2+waves (Cotrina
et al., 1998; Arcuino et al., 2002). In AQP4-KO cultured mouse
astrocytes, Cx43 expression was down-regulated (Nicchia et al.,
2005), indicating an interaction between this connexin and water
channel type.
Cx43 and APQ4 may work in tandem to allow water flux
and movement of ions and small molecules from the brain
parenchyma toward the vasculature. At perivascular end-feet
these ions and small molecules become extruded via their respec-
tive channels. A prime example would be K+ siphoning when
extracellular K+ and water may permeate through Cx43 and are
extruded through Cx43 and AQP4 respectively (Nicchia et al.,
2005). Simultaneous action of Cx43 and AQP4, together with K+
channels (Kir4.1/Kir5.1) would also ensure efficient removal of
K+ from astrocytes into the vasculature (Lichter-Konecki et al.,
2008). Indeed, increased extracellular levels of K+, as seen during
ischemia, have been shown to increase gap junctional coupling
and AQP4 expression (De Pina-Benabou et al., 2001).
Although the mechanisms are not clear, a functional relation-
ship could exist, possibly by coordination of ion and water move-
ments through Cx43 when AQP4-mediated flux is compromised
(Nicchia et al., 2005; Chanson et al., 2007). Such a functional
relationship could play a pivotal role in distribution of edema
through astrocyte syncytial networks (Fukuda et al., 2013a).
Effect of Glutamate on AQP4
Under physiological conditions, glial glutamate uptake is
achieved primarily through the major glutamate astrocyte buffer-
ing gateway in the brain–high-affinity Na-dependent transporters
such as GLT-1 (EEAT2) or GLAST (EEAT1) (Nicholls and
Attwell, 1990). Glutamate uptake via these transporters is accom-
panied by Na+ uptake and water influx aided by AQP4. Glu-
tamate also activates group I metabotropic receptors (mGluR),
which in turn activate phospholipase C (PLC) and generates inos-
itol 1,4,5- triphosphate (IP3) triggering Ca
2+ release from intra-
cellular stores and activates calcium/calmodulin-dependent pro-
tein kinase II (CaMKII) and nitric oxide synthase (NOS). Group
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I mGluR also regulate water permeability of AQP4-expressing
astrocytes (Gunnarson et al., 2008).
A link between glutamate release and AQP-4 expression has
also been observed in acute rat hippocampal slices (Zeng et al.,
2012). AQP4 knockout mice were found to decrease glutamate
uptake by astrocytes via down-regulation of GLT-1, with increase
in extracellular glutamate levels (Zeng et al., 2007, 2012). Exces-
sive glutamate levels lead to activation of mGluR with increase in
hypo-osmotic swelling in tissue slices (Zeng et al., 2012). AQP4
and GLT-1 in fact, localize as a functional complex on astrocyte
membranes (Zeng et al., 2007). AQP4 expression correlated with
the GLT-1 expression pattern while astrocytes positive for AQP4
were also shown to be positive for GLT-1 (Mogoanta et al., 2014).
In ischemia, an energy crisis leads to ionic disturbances with
intracellular accumulation of Na+ and extracellular K+ and
increased water influx from the extracellular space. As ionic gra-
dients cannot be regulated efficiently in these conditions, astro-
cyte AQP4 may have a detrimental effect by facilitating water
entry which aggravates cytotoxic edema. Excessive glutamate lev-
els also up-regulate AQP4 astrocyte activity via mGluR activa-
tion, which further exacerbates the edematous insult (Gunnarson
et al., 2008).
Ischemic brain damage ultimately leads to neuronal death
by excitotoxicity so that the control of extracellular glutamate
levels and prevention of excitotoxicity determine the degree
of cell survival around the ischemic area (Choi and Rothman,
1990). AQP4 modulation by metabotropic receptors or signal-
ing chain stimuli, particularly inhibition of AQP4 up-regulation,
offers a possible therapeutic avenue to minimize brain edema
from the excessive glutamate that is released during ischemia
(Gunnarson et al., 2008; Pa Santes-Morales and Cruz-Rangel,
2010).
AQP4, Cell Migration, and Glial Scar
Formation
The ability of astrocytes to form scars that inhibit axon regen-
eration and neuronal repair has been recognized for over a
century. The astroglial defensive response is manifested by a
series of co-ordinated processes that involve changes in the
expression of genes and result in the appearance of multi-
ple phenotypes specific to a particular pathology (Burda and
Sofroniew, 2014; Pekny et al., 2014). Nevertheless, a growing
body of evidence indicates that reactive astrocytes exert many
beneficial functions and that astrocytes have a wide spectrum
of potential and often subtle responses to CNS insults, scar
formation being one that lies at the extreme end in terms of
its severity. In particular, models of spinal cord injury have
shown that the glial scar and reactive astrocytes may con-
fer protective advantages to recovering CNS tissue which then
progress into a maladaptive response that renders the tissue non-
responsive and detrimental to repair. Studies of gene expression
in astrocytes following MCAO in mice showed up-regulation
of many of the proteins present in reactive astrocytes and glial
scar following spinal cord injury. This suggests that the func-
tion of the glial scar in stroke would be similar to that in
spinal cord injury (Zamanian et al., 2012). Inhibition of reactive
astrogliosis generally reduces neuronal viability, affects nervous
tissue regeneration, suppresses neurogenesis and compounds the
neurological outlook (Robel et al., 2011; Burda and Sofroniew,
2014).
After an ischemic insult, reactive astrocytes become metabol-
ically activated by augmenting their nuclear size and increas-
ing the number of mitochondria and ribosomes. They migrate
toward the lesion and remodel it to form a packed glial scar (Pan-
ickar andNorenberg, 2005). Accumulated glial filaments contain-
ing GFAP, vimentin and/or nestin are hallmarks of hypertrophic
astrocytes during ischemia (Pekny and Nilsson, 2005; Sofroniew
and Vinters, 2010). The appearance of reactive astrocytes with
GFAP expression is concurrent with AQP4 up-regulation (Eng
et al., 2000). The glial scar also contains reactive microglia which
express AQP4 (Tomás-Camardiel et al., 2004).
Migration of reactive astrocytes is seen as an important com-
ponent of glial scar formation around the damaged tissue and
results of in vitro and in vivo experiments support the notion
of AQP4-facilitated migration of reactive astrocytes toward the
site of injury. An in vivo model of reactive gliosis and astroglial
cell migration produced by cortical stab injury showed that glial
scar formation was remarkably impaired in AQP4-null mice
because of reduced migration of reactive astroglia toward the site
of injury (Saadoun et al., 2005). Based on these findings, it has
been proposed that AQP4 accelerates astroglial cell migration
by increasing plasma membrane permeability to water, which
increases the transmembrane water fluxes that take place dur-
ing cell movement (Figure 2B). Osmotic gradients created by
actin cleavage and ion uptake lead to water flux mediated by
AQP4 which facilitates lamellipodial extension and speeds up cell
migration (Verkman, 2005). High AQP4 expression may con-
tribute to cell adhesion and facilitate adhesion between astrocytes
so that a new barrier or the glia limitans is formed (Hiroaki
et al., 2006; Badaut et al., 2011). Despite data still being frag-
mentary, these studies provide new insights into why APQ4
is up-regulated in astrocytes during ischemia, with no edema-
related effects. Strategies aimed at AQP4 may help attenuate
glial scarring and enhance neuronal regeneration (Saadoun et al.,
2005).
AQP4 and Neuroinflammation
Ischemic stroke-related brain injury triggers inflammatory cas-
cades that further amplify tissue damage. Neuroinflammation is
usually accompanied by edema and BBB disruption. It is dis-
tinct from peripheral inflammation (Galea et al., 2007; Graeber
et al., 2011), being characterized by microglial activation, reactive
astrocytosis and activation of chemokines and cytokines. In cere-
bral ischemia this may be beneficial or detrimental, depending on
the timing and severity of the insult.
A central role of AQP4 in neuroinflammation is in the estab-
lished astrocyte proliferative response in ischemia (Kuppers et al.,
2008). AQP4 was also detected on reactive microglia follow-
ing LPS injection in rats, but the significance of this expres-
sion is poorly understood (Tomás-Camardiel et al., 2004). AQP4
is also upregulated in vasogenic edema, where it occurs as a
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result of BBB disruption. This suggests associations between
AQP4-regulated water flux and neuroinflammation (Fukuda
and Badaut, 2012). Pro-inflammatory mediators including toxic
cytokines IL-1 and TNF-α released by both activated microglia
and by neutrophils, have been found to release matrix metallo-
proteinases (MMPs) in in vitro astrocyte cultures (Candelario-
Jalil et al., 2009; Xia et al., 2010). MMPs are primary components
of the neuroinflammatory response being partially responsi-
ble for BBB disruption (Rosell et al., 2006). MMP-9 degrades
agrin while MMP-3 degrades dystroglycan (Wolburg-Buchholz
et al., 2009), both of which play a pivotal role in OAP for-
mation and AQP4 assembly in astroglial end-foot membranes
(Noel et al., 2009; Fallier-Becker et al., 2011). The neuroinflam-
mation produced by ischemia leads to upregulation of MMPs
which cause AQP4-OAP disruption, and possibly exacerbate
BBB disturbance and worsen the edema (Rosell et al., 2006).
Development of vasogenic edema also amplifies BBB disrup-
tion due to increased hydrostatic pressure. AQP4 may also have
a role in neuroinflammation via edema resolution (Figure 5).
Up-regulation of perivascular AQP4 causes enhanced resorp-
tion of extracellular edema fluid which eases hydrostatic pres-
sure and BBB disruption. As a result there is less neutrophil
infiltration, less pro-inflammatory cytokine production and less
MMP activation (Fukuda and Badaut, 2012). Stretch-activated
Cl− channels expressed on microglia are activated to a lesser
extent because of pressure differences due to resorption of edema
fluid. This leads to less activated microglia and a decrease in
pro-inflammatory cytokine release (Eder et al., 1998; Fukuda and
Badaut, 2012).
It can thus be postulated that AQP4 may exacerbate cytotoxic
edema during the acute stage (first few hours) of ischemia, and
that during later stages of edema (7 days and later), delayed but
pronounced AQP4 up-regulation may play a beneficial role by
promoting edema resolution and attenuating neuroinflammation
by inhibition of microglial activation and astrogliosis (Tourdias
et al., 2011; Fukuda and Badaut, 2012).
AQP4 is also seen to play an inhibitory role in post-ischemic
inflammation (Shi et al., 2012). The inflammatory mediators cys-
teine leukotrienes (CysLTs), by activation of CysLT1 and CysLT2
receptors precipitate post-ischemic inflammation (Fang et al.,
2006; Zhao et al., 2011). AQP4−/− mice showed more pro-
nounced up-regulation of CysLT1 and CysLT2 expression after
30min of MCAO and enhanced inflammatory response (Shi
et al., 2012). Inflammatory reaction was also exacerbated in these
FIGURE 5 | Schematic summary of a beneficial role AQP4
upregulation plays during the edema resolution phase. The
upregulation of AQP4 causes increased water clearance from the tissue,
which in turn causes decreased BBB disruption because of decreased
pressure, and there is less neutrophil infiltration and decreased pro
inflammatory cytokines. This causes decreased MMP production
(Candelario-Jalil et al., 2009) which possibly results in less destruction of the
basal lamina and tight junctions and causes an even greater decrease of the
BBB. In another pathway (dotted lines), the increased water clearance from
the tissue and extracellular space causes changes in the osmotic pressure,
changing the activation state of the stretch activated ion channels expressed
in microglia (Lewis et al., 1993; Eder et al., 1998; Schlichter et al., 2011),
causing less microglial activation, leading to decreased pro-inflammatory
cytokine release. The resulting decrease in BBB disruption/permeability leads
to decreased vasogenic edema or better edema resolution. Finally, this
scheme outlines the potential link between AQP4, edema and
neuroinflammation. Reproduced with permission from Fukuda and Badaut
(2012).
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mice which also had a reduced number of CD4+ and CD25+
regulatory T cells (Chi et al., 2011). This may suggest that the
absence of AQP4 disrupts these immunosuppressive regulators
(Shi et al., 2012).
Aquaporin 1
AQP1 is expressed on the apical surface of the choroid plexus
(Gonen and Walz, 2006), which forms the border between the
CSF and blood, the major fluid compartments in the brain
(Masseguin et al., 2000; Papadopoulos et al., 2007). It is most
notably absent in the cerebrovascular endothelial cells, except
in the circumventricular organs (Nielsen et al., 1993; Wilson
et al., 2010). In the spinal cord, AQP1 is expressed in the
ependymal cells lining the central canal, but more robustly
in the sensory fibers of the superficial laminae of the dor-
sal horn (Oshio et al., 2005; Shields et al., 2007; Nesic et al.,
2008).
AQP1 and Cerebrospinal Fluid
Due to the location of its expression, AQP1 is believed to have
a role in CSF secretion under physiological conditions (Amiry-
Moghaddam and Ottersen, 2003c). CSF production is driven by
an osmotic gradient brought about by Cl−/HCO3− and Na+/H+
exchangers located in basolateral membranes of the choroid
plexus (Keep et al., 1994; Wu et al., 1998; Nakamura et al., 1999).
AQP1 on apical membranes may explain the high osmotic-
diffusional water permeability ratio in the choroid epithelium,
indicating the existence of an aqueous pathway (Oshio et al.,
2005). In AQP1-null mice, osmotic water permeability in the
choroid plexus is reduced by five-fold compared to that in
wild-type mice. This translates to a 50% reduction in intracra-
nial pressure (Papadopoulos and Verkman, 2013) and may have
important implications in ischemia. That AQP1 is not the sole
player in CSF secretion is demonstrated by a mere 25% reduction
in CSF secretion rate in AQP1-null mice compared to wild-type
(Oshio et al., 2005). The role of this water channel in CSF pro-
duction is still ambiguous and to date, studies using AQP1−/−
mice have not yet established it either (MacAulay and Zeuthen,
2010).
While AQP1 expression in astrocytes is linked to CSF for-
mation, its neuronal expression may be linked to neuroplasticity
and repair because of its co-localization with growth-associated
protein-43 (GAP-43) (Nesic et al., 2008). AQP1 is implicated
in malignant brain tumors, where it becomes expressed in the
microvascular endothelium and reactive astrocytes in rodents
and humans. This expression may aid in augmenting the BBB
water permeability of such tumors (Papadopoulos et al., 2007).
Expression of AQP1 on reactive astrocytes points to an unan-
ticipated function of AQP1 in cell migration. This may have
implications in recovery from stroke but the relationship between
the two has not been investigated (Saadoun et al., 2005; Verk-
man, 2005). AQP1 inhibitors could be potentially beneficial in
counteracting excessive CSF accumulation in ischemic stroke and
in hydrocephalus or intracranial hypertension (Tait et al., 2008;
Huber et al., 2012).
Aquaporin 9
AQP9 forms part of the aquaglyceroporin family with which it
shares a broad range of permeability to diverse molecules such as
water, glycogen, lactate, urea, purines, pyrimidines, and mono-
carboxylates (Yamamoto et al., 2001). Expressed mostly in the
liver and in the CNS, AQP9 is also expressed in the spinal cord
and retina. In contrast to AQP4, which is expressed primarily in
the foot processes of astrocytes, AQP9 is reported to be expressed
throughout the astrocyte cell bodies and processes in the brain.
AQP9 was also detected in cerebrovascular endothelia, astrocytes
of the glia limitans, white matter tracts and tanyctes in circum-
ventricular organs (Elkjaer et al., 2000; Badaut et al., 2001; Nic-
chia et al., 2001; Badaut and Regli, 2004). AQP9 is also expressed
in neurons but appears to be concentrated in catecholaminer-
gic and glucose-sensitive neurons (Badaut and Regli, 2004) and
mitochondria (Amiry-Moghaddam et al., 2005), raising the pos-
sibility that AQP9 is involved in brain energy metabolism. AQP9
regulation is thought to involve PKC and PKA pathways. AQP9
mRNA is up-regulated by PKA and down-regulated by PKC
pathways in astrocyte cultures. However, direct regulation by
phosphorylation has not been demonstrated to date (Badaut and
Regli, 2004; Papadopoulos et al., 2007; Badaut, 2010).
The role of AQP9 is still unclear although it is implicated in
several pathways and its expression is altered in pathophysio-
logical conditions (Badaut and Regli, 2004). Its permeability to
glycogen and lactate suggests that it is involved in metabolite dif-
fusion (Badaut et al., 2002; Papadopoulos et al., 2007; Badaut,
2010). AQP9 permeability varies with changes in pH, such that
permeability to lactate increases four-fold when pH decreases to
5.5 (Tsukaguchi et al., 1998). Expression of AQP9 is affected by
metabolic challenge. In diabetes for instance, this channel is over-
expressed in neurons (Badaut, 2010; Badaut et al., 2011). Chan-
nel expression is also enriched in mitochondrial membranes, but
not in all brain mitochondria, showing a preference for astrocyte
mitochondria and subsets of neurons (Amiry-Moghaddam et al.,
2005). AQP9 is implicated in control of extracellular milieu from
its expression in astrocyte cell processes and cell bodies without
vasculature contact. It is also thought to play a buffer role in active
neurons and axons (Badaut et al., 2001).
AQP9 in Cerebral Ischemia
AQP9 is up-regulated in reactive astrocytes at the border of the
infarct after transient MCAO in mice but mainly in the cortex,
ventral pallidum and nuclei of the amygdala (Badaut et al., 2001)
with significant induction after 24 h and further increase over
time (de Castro Ribeiro et al., 2006; Badaut, 2010). Expression
was greatest at 7 days after stroke, indicating a role in reactive
astrocyte and glial scar formation (de Castro Ribeiro et al., 2006).
The similar regional distribution of up-regulated AQP4 indi-
cates a potential involvement of both AQPs in water fluxes and
edema formation (Marmarou, 2007; Badaut et al., 2011). How-
ever, no association with edema was found for AQP9 suggest-
ing that in ischemia, AQP9 may have a more significant role as
a metabolite channel (Bertrand et al., 1992; Schulz et al., 2000;
Frykholm et al., 2001; Kuo et al., 2003). In contrast to AQP4,
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AQP9 is not polarized on astrocyte end-feet and its pattern of
expression is thought to support a role in the ‘lactate shuttle’
model as proposed by Pellerin and Magistretti (1994). Trans-
port of lactate into mitochondria is considered to be one of the
major roles of AQP9. When ischemic lactic acidosis is exposed
to the relatively high pH of the mitochondrial membrane, it is
deprotonated and serves to attenuate the proton gradient across
the membrane. This concentration gradient is particularly pro-
nounced in hypoxia-ischemia, and favors lactate uptake through
AQP9 in mitochondria (Amiry-Moghaddam et al., 2005). AQP9
may favor lactate clearance from the ECS and facilitate move-
ment of lactate between astrocytes and neurons, thus promot-
ing neuronal recovery by aiding in the provision of the energy
substrate (Badaut, 2010). Up-regulation of AQP9 after ischemia
could therefore be viewed as a cell survival mechanism and may
represent a novel pathway in ischemic pre-conditioning (Amiry-
Moghaddam et al., 2005). However, the precise roles of AQP9 are
speculative (Badaut, 2010) and the lack of suitable and more spe-
cific AQP9 antibodies hinders further progress (Papadopoulos
et al., 2007; Rojek et al., 2007).
AQP3, AQP5, and AQP8
AQP3, 5, and 8 have been found in neuronal and astrocyte
cultures, and AQP8 has also been found in oligodendrocytes
(Yamamoto et al., 2001; Badaut et al., 2002). AQP5 expression
may be attenuated during hypoxia and up-regulated after re-
oxygenation. It may thus partake in resolution or progression
of edema (Yamamoto et al., 2001). The tandem up-regulation
of both AQP5 and APQ4 may be a mechanism by which cere-
bral edema is attenuated by mild hypothermia under hypoxic
conditions (Fujita et al., 2003). The physiological roles of these
AQP members and their implications in stroke pathophysiology
remain to be elucidated (Badaut et al., 2002).
Practical Implications and Future Direction
Ischemic stroke is a major cause of long-term disability in
humans, but effective treatments are lacking. Studies on AQPs
provide a compelling rationale for development of AQP modu-
lators that have the potential for improving ischemic pathologies
(Table 1). Although some potential AQP modulators have been
identified, challenges and speculation still abounds (Papadopou-
los and Verkman, 2013). Development of potential therapeutic
agents targeted at AQPs for management of ischemia is only suc-
cessful when the type of stroke and the timing of intervention
are taken into consideration. Furthermore, the variety of AQP
expression patterns adds to the complexity of treating this disease
(Badaut et al., 2011).
A major outcome measure in the treatment of ischemia is
the abatement of the edematous process (Badaut et al., 2011).
AQP modulators are expected to decrease brain water content
and thereby decrease intracranial pressure to improve cerebral
perfusion, alleviate herniation and decrease the risk of death
(Papadopoulos and Verkman, 2008). They would need to be
administered for a few days when edema persists and would
also be expected to act acutely. Candidate drugs need to possess
good pharmacology, be stable and non-toxic and capable to cir-
cumvent the BBB. Most of the information on potentially viable
treatment options concerns the channel AQP4. Because of its
dual action, inhibitors or activators of AQP4 could theoreti-
cally be applied at different stages of stroke to exert specific
actions. For instance, AQP4 inhibitors may be beneficial in the
early course of stroke (cytotoxic phase) but potentially detri-
mental later on (vasogenic phase) (Papadopoulos and Verkman,
2008).
There are no specific AQP4 inhibitors with clinical use-
fulness, although AQP4 down-regulation can be achieved by
inhibition of RNA or modulators based on the crystal struc-
ture of AQP (Papadopoulos and Verkman, 2007; Saadoun and
Papadopoulos, 2010). Drug discovery is also possible through rig-
orous morphological assays, water-based transport screens and
nanotechnology-based screens (Frigeri et al., 2007). siRNA strat-
egy permitted to show the potential of a specific AQP4 inhibitor
in a rat model of juvenile traumatic brain injury. This study
showed a decrease in edema formation and functional recov-
ery post injury (Fukuda et al., 2013b) in parallel to neuroimag-
ing approach findings (Manley et al., 2000). One area of recent
progress is the immunosuppressive approach to block the onset
of neuromyelitis optica by a combination of methods based
on anti-AQP4 antibody binding to pathogenic autoantibodies
and screening of blockers of the autoantibody-AQP4 interaction
(Verkman et al., 2013).
Compounds that have been tested include bumetanide
(NKCC1 inhibitor), a clinically safe diuretic, which is thought
to block the AQP4 channel and water permeability in X. lae-
vis oocytes (Migliati et al., 2009). In experimental rodent models
of ischemia this prevents edema formation through decreases in
AQP4 expression. However, this effect may also be attributed to
the potential blockade of the Na-Cl-K co-transporter in endothe-
lial cells (Migliati et al., 2010; Badaut et al., 2011). Acetazolamide
and sulphonamide, as well as several other anti-epileptic drugs
have reported to inhibit AQP4 expressed in X. laevis oocytes
(Huber et al., 2007, 2009). In another study, AQP4-mediated
water conduction in proteoliposomes was reversibly inhibited
by acetazolamide (Tanimura et al., 2009). In a recent rat focal
ischemia model, pre-treatment with piroxicam was shown to
be a potent AQP4 regulator, rendering neuroprotection (Bhat-
tacharya et al., 2013).
Also reported to confer neuroprotective effects in ischemia is
erythropoietin. Intracerebroventricular administration 24 h prior
to induction of ischemia resulted in a 47% reduction of infarc-
tion in mice subjected to MCAO (Bernaudin et al., 1999). Its
modes of action include a transient increase in intracellular Ca2+
(Morishita et al., 1997) and attenuation of NO-induced cell death
(Sakanaka et al., 1998). However, further studies are needed
to further demonstrate the connection of these in relation to
ischemia amelioration.
A potentially viable compound which is postulated to inter-
act with AQP4 and which may be useful in ischemic stroke is
edaravone, a free radical scavenger that readily crosses the BBB.
In a rat transient focal ischemia model, it significantly reduced
the area of infarction and improved neurological scores when
administered after 24 h of reperfusion. Furthermore, edaravone
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TABLE 1 | Summary of different treatments with potential for clinical use in ischemia-evoked cerebral edema and their effects on AQP expression.
Treatment AQP expression after ischemia
and treatment
Ischemic model References
Acetazolamide Decreases AQP4 and AQP1
permeability
Pure proteins reconstituted into
liposomes; Xenopus oocytes
Ma et al., 2004; Tanimura et al., 2009
Anti-miR-320a Increases AQP4 and AQP1
expression
Rat transient MCAO, 60min Sepramaniam et al., 2010
AqB013 Non-selective AQP1/APQ4 inhibitor Xenopus oocytes Migliati et al., 2009; Yool et al., 2009
Arginine vasopressin V1 (AVPV1)
antagonist
Increases AQP4 expression Mouse transient MCAO, 60min Liu et al., 2010
Bumetanide Decreases AQP4 permeability Mouse transient MCAO, 60min Migliati et al., 2009
Edaravone Decreases AQP4 expression Rat transient MCAO, 90min Kikuchi et al., 2009
EZA (6-ethoxy-benzothiazole-2-
sulfonamide)
Decreases AQP4 permeability Xenopus oocytes Huber et al., 2007
Furosemide Decreases AQP4 and AQP1
permeability
Xenopus oocytes Migliati et al., 2009; Ozu et al., 2011
miR-320a Decreases AQP4 and AQP1
expression
Rat transient MCAO, 60min Sepramaniam et al., 2010
Neuregulin Decreases AQP4 expression Rat transient MCAO, 90min Li et al., 2008
NSC164914
(tributyl-(2,4,5-trichlorophenoxy)stannane);
NSC168597 (tributyl-chloroplumbane)
Decrease AQP4 and AQP1
permeability
Fluorescence-based assays of
volume changes in primary
cultures of mouse astrocytes
Mola et al., 2009
PMA (phorbol 12-myristate 13-acetate) Decreases AQP4 expression Rat transient MCAO, 120min Kleindienst et al., 2006; Fazzina et al., 2010
Picroside II Decreases AQP4 expression Rat BCCAO 60, 90, 120, 150min Li et al., 2010, 2013
Piroxicam Decreases AQP4 expression Rat transient MCAO, 60min Bhattacharya et al., 2012
Probenecid Decreases AQP4 expression Mouse transient MCAO, 60min Xiong et al., 2014
Propofol Decreases AQP4 expression Rat transient MCAO, 90min Zheng et al., 2008
TEA (Tetraethylammonium) Decreases AQP1 permeability Xenopus oocytes Brooks et al., 2000
TGN-020-(2-(nicotinamoyl)-1,3,4-
thiadazole)
Decreases AQP4 permeability Mouse transient MCAO, 120min Igarishi et al., 2011
Abbreviations: MCAO, Middle Cerebral Artery Occlusion; BCCAO, Bilateral Common Carotid Artery Occlusion.
markedly reduced AQP4 immunoreactivity and protein levels in
the cerebral infarct area. It is postulated that by suppression of
AQP4 expression, edaravone exerts its influence to reduce cere-
bral ischemic injury (Kikuchi et al., 2009). Similarly antioxidant
administration of melatonin showed reduced AQP4 expression
in a study involving hypoxic rats (Kaur et al., 2006). Propofol
has also been reported to down-regulate AQP4 expression. In a
model of MCAO and reperfusion, infusion of propofol prior to
ischemia decreased brain edema and reduced over-expression of
AQP4. This may be mediated by altered regulation of the PKC
pathway in the brain, or attenuation of extracellular glutamate
levels (Zheng et al., 2008). In a focal ischemia mouse model with
reperfusion, administration of Neuregulin-1β (NRG-1β) con-
fered neuroprotection through regulation of the activation of
AQP4 and inhibition of the mitochondrial apoptosis pathway.
The mechanism by which this occurs however, remains partly
elusive (Li et al., 2008).
Since AQP4 aids in migration of reactive astrocytes toward
an injury site, candidate AQP4 blockers may augment neu-
ronal generation by attenuating reactive gliosis and hence
mitigate potentially detrimental glial scar formation (Saadoun
and Papadopoulos, 2010). Migration can also be modu-
lated by altering extracellular osmolarity or transcellular
osmotic gradients, since AQP4 supports water flux into and
out of migrating astrocytes (Papadopoulos and Verkman,
2013).
Agmatine attenuated AQP1 expression in a mouse model
of transient ischemia. This translates into decrease of cerebral
edema and brain swelling, possibly through reduction of matrix
metalloproteinases-2 and -9 (Kim et al., 2008), which are associ-
ated with BBB disruption and could thus offer another possible
therapeutic approach in treatment of brain edema (Kim et al.,
2010).
Conclusion
Substantial advancements have been made in the field of AQP
studies and their role in several pathophysiologies. Regulation of
water transport constitutes an integral part of ischemic stroke
amelioration and thus continuous efforts are required in the
hope of elucidating further mechanisms that could improve out-
comes of this disease. Careful application of various AQP modu-
lators at different phases of stroke has the potential of amplifying
favorable outcomes and of attenuating undesirable ones, making
them clinically highly relevant. Finally, the development of new
tools to identify selective modulators with subtype specificity and
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affinity for select AQPs is poised for exciting progress in basic life
sciences and medicine.
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